Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 18/20 | 0.61 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.55 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19351793 | 0.93 | FOLH1 (0.69) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL16657558 | 0.93 | FOLH1 (0.69) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL19351949 | 0.93 | FOLH1 (0.69) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL19351945 | 0.93 | FOLH1 (0.69) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL19351795 | 0.93 | FOLH1 (0.69) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL23567812 | 0.88 | FOLH1 (0.63) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL10134716 | 0.83 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL15383531 | 0.83 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL19788649 | 0.82 | FOLH1 (0.54) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL15158795 | 0.81 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11638765-B2 | Double-labeled probe for molecular imaging and use thereof | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2023-05-02 | — | — | US | disclosed |
| US-20150110715-A1 | Double-Labeled Probe for Molecular Imaging and Use Thereof | RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150110715-A1 | Double-Labeled Probe for Molecular Imaging and Use Thereof | CD47, ANXA5, CD44 | FOLH1 36/4885NAALAD2 2184/4885RIMKLA 3722/4885 |
| US-11638765-B2 | Double-labeled probe for molecular imaging and use thereof | ANXA1, ANXA5, CD47 | FOLH1 200/4885NAALAD2 3824/4885RIMKLA 2260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.